June 19 is World Sickle Cell Day.
At 18 months, I was diagnosed with the most severe type of sickle cell anemia: HbSS. Its a mutation that occurs when a child inherits two genes of hemoglobin S from each parent. The rigid red blood cells clump together, causing blockages in blood flow that lead to chronic anemia, episodic pain crises, and widespread organ damage.
With the disease progression, my symptoms became harder to manage as I aged. For years, I arduously searched for a cure and in 2019, I participated in a clinical research trial, receiving an allogeneic stem cell transplant from a matched sibling donor at the National Institute of Health (NIH) in Bethesda, Maryland.
A Stranger in My Own Body
With sickle cell behind me, I was optimistic and hopeful but the road to recovery was challenging. I suddenly experienced an identity crisis; questioning my new normal and struggling to adapt to life after sickle cell anemia.
Physically, I had the immune system of a two-year-old but the body of a middle-aged woman because this debilitating blood disease wreaked havoc on my tissues, bones, and organs. Mentally, I was crippled by an influx of opposing emotions (i.e. anger, fear, sadness, joy) and couldnt escape survivors guilt. As I tried to push past fear, my friends called me brave. How ironic.
Curative treatment therapies like hematopoietic transplantation and gene therapy eliminate symptoms and stop disease progression. However, after transplantation, the patient becomes a carrier of the sickle cell trait (AS), meaning the disease can still be passed on to children. Education around the transplant experience has inspired a niche community of advocates; patients who are turning their pain into purpose.
As a sickle cell thought-leader, Ive used my patient experience as an added advantage by consulting for healthcare technology platforms and genomic biotech companies. For researchers, advisory panels can simplify educational materials, refine trial designs, train members of the health team, and share insights that optimize the clinical trial experience for upcoming therapies.
The Power of Media
Growing up, I was truly disheartened by the depiction of sickle cell disease (SCD) in the media. Characters in movies and TV shows were given story arcs that purported stigma and misinformation among the general public, so my advocacy goal was to take control of the narrative through proactive engagement with the media.
When we hear the phrase representation matters, it is not limited to race, religion, or sexual orientation; it also applies to rare diseases and the disabled community. Diverse perspectives in the media have the power to transform prejudice into empathy and make the invisible visible.
In my professional opinion, showcasing gamuts of the patient experience using perceptive awareness campaigns can encourage the healthcare industry to see patients as people first and lean toward providing compassionate and respectful care.
What is Optimal Advocacy?
In the sickle cell community, advocacy is multi-dimensional with a focus placed on protecting the patients rights, improving communication between patients and providers, activating a network of support, and proposing policies that deliver high-quality care.
While working on a project with my mentor, Vence Bonham (JD), acting deputy director of the National Human Genome Research Institute, I got a lesson in real advocacy. He believes that optimal advocacy should empower key stakeholders at every level including patients, caregivers, providers, researchers, healthcare organizations, pharmaceutical companies, community groups and congressional committees.
For decades, the standard of care was breached by implicit bias and racist attitudes expressed by health care workers who ignorantly dehumanized people with sickle cell disease. Patients were labeled as drug seekers and accused of faking pain, resulting in inadequate treatment and more suffering. Effective advocacy should facilitate change and address the needs of the community.
As a facilitator in Bonhams group, I met three extraordinary women who are advocates for change on every level family, system, community and policy. Their exceptional leadership and grassroots efforts are actively combating the stigma of sickle cell disease across the country.
Wanda Whitten-Shurney, M.D., is the medical director of the Michigan chapter of the Sickle Cell Disease Association of America (SCDAA). She is a general pediatrician who coordinates the newborn hemoglobinopathy screening program for the Michigan Department of Health and Human Services. If a child is born with sickle cell disease, the SCDAA alerts the family, gets the child into pediatric care and coordinates penicillin prophylaxis.
Inspired by the legacy of her late father, Charles Whitten, M.D., founder of the National Association for Sickle Cell Disease, advocacy is very important to Whitten-Shurney.
Our patients are dying and a lot of these deaths could have been prevented, she says. I think the reason patient care is so poor is because of the constant stigmatization of patients as drug-seekers. Doctors dont pay enough attention to sickle cell patients so my role is to teach them how to advocate for better care.
Whitten-Shurney is a big part of fighting the stigma of sickle cell disease in Michigan by getting patients out of the emergency room and focusing on holistic wellness. In the future, she wants to create an adult multidisciplinary care center a statewide hub and spoke model where patients can receive primary care, specialized sickle cell care, and psychosocial support.
Kim Smith-Whitley, M.D., is the executive vice president and head of research and development for Global Blood Therapeutics (GBT). She is a world-renowned hematologist and an active sickle cell advocate with over 30 years of research experience in pulmonary complications, transfusion-related complications, and health care utilization.
In 2019, Global Blood Therapeutics announced the approval of Oxbryta, a disease-modifying prescription medication that stops hemoglobin from sickling in adults and children over the age of four. Oxbryta is an oral therapy taken once daily that directly inhibits sickle hemoglobin polymerization, which is the root cause of SCD.
As a pediatric hematologist, I saw the social inequities and stigma that impacted the sickle cell community because it mostly consists of Black and brown people, she says. I think we need to find a way to increase awareness so that we can draw companies that are interested in developing and delivering therapies that truly address the underlying cause of sickle cell, thereby improving survival. She believes that raising the voice of individuals with sickle cell will empower them to advocate for high-quality care and shared decision-making.
Teonna Woolford is the CEO of the Sickle Cell Reproductive Health Education Directive (SCRED), the first 501(c)3 non-profit that focuses on reproductive health. The organization offers fertility preservation grants to sickle cell patients undergoing curative therapies.
Some people think that given the complications of sickle cell disease, women shouldnt be encouraged to conceive. Sickle cell patients are whole and to honor that wholeness, our reproductive health must be prioritized, she says.
SCRED provides education on reproductive health concerns, establishes standards for effective and high-quality reproductive health care, and advocates for policies that can improve access to comprehensive care.Woolfords passion for advocacy has inspired discussions with world leaders like former First Lady Michelle Obama and the late congressman John Lewis.
Advocates play a critical role in convincing lawmakers and health leaders to reverse policies and allocate resources to fund treatment advancements for SCD patients globally.Whether youre a physician, caregiver, or patient, a seat at the table is a rare opportunity to effect change and improve healthcare.
TOPICS: health and wellness sickle cell disease world sickle cell day
Read the original here:
Erasing The Stigma Of Sickle Cell Disease Through Advocacy - Essence
- New drug candidate uses novel absorption method to target cancer cells in mice - Michigan Medicine - August 22nd, 2022
- Jianping Fu Mechanical Engineering - University of Michigan - July 11th, 2022
- Cell Culture Market Key Drives Zeroing In On The Main Merchants | Danaher Corporation, Thermo Fisher Scientific Designer Women - Designer Women - July 11th, 2022
- This One Group Of People Holds The Key To Staying Young, Study Says Eat This Not That - Eat This, Not That - May 2nd, 2022
- Primary Cells Market 2022 is set to experience a significant growth rate | PromoCell GmbH, HemaCare Corporation, Thermo Fisher Scientific ... - May 2nd, 2022
- 3D Cell Culture Market to 2030 | Industry Statistics, Emerging Demands, Forecast to 2030 | 3D Biotek, LLC Advanced Biomatrix, Inc. Becton, Dickinson... - May 2nd, 2022
- Oral Cavity | histology - University of Michigan - April 19th, 2022
- Unraveling Stem Cells' Secrets: Immortality of Germline Cells and the Function of Junk DNA - SciTechDaily - April 19th, 2022
- Scientists De-Aged a Woman's Skin Cells by 30 Years - The Daily Beast - April 19th, 2022
- Longboat residents recall the greatest gifts - YourObserver.com - December 24th, 2021
- Nebraska Athletics News: Recruiting Season, Living Robots and Stuck in IKEA - Corn Nation - December 10th, 2021
- Duke Faculty Promoted or Appointed to the Rank of Full Professor - Duke Today - November 8th, 2021
- Lab-Growing Everything Might Be The Only Way To Attain A Sustainable World - Intelligent Living - November 8th, 2021
- Male Infertility Could Be Treated With Monkey Cells; New Study Shows How These Animals Could Help Address the Condition - Science Times - October 28th, 2021
- Insights & Outcomes: Place cells, planarians, and 'prewet' proteins - Yale News - October 28th, 2021
- Using a mini heart model to develop new therapies - MSUToday - October 5th, 2021
- Rowan University hosts National Science Foundation research program for undergrads - Rowan Today - August 31st, 2021
- Loss of a top autism gene may alter neuron structure - Spectrum - January 17th, 2021
- Rogel team receives $11.2M to leverage the microbiome against GVHD - Newswise - October 28th, 2020
- Latest Update 2020: What Are the Key Players Evolving In the Growth of the 3D Cell Culture Market? - re:Jerusalem - October 28th, 2020
- Listings - CON, THE on ABC | TheFutonCritic.com - The Futon Critic - October 15th, 2020
- ABC News Debuts New Primetime Series THE CON Narrated by Whoopi Goldberg - Broadway World - October 8th, 2020
- HOME GROWN: Pumpkins best left on the vine for as long as possible - The Oakland Press - October 8th, 2020
- Official Missteps in Michigan's Worst Covid Prison Outbreak - The Intercept - September 29th, 2020
- Regenerative medicine and war: The next breakthrough in treating injured veterans? - Genetic Literacy Project - September 29th, 2020
- Hematopoietic Stem Cells (HSCs) Market Primary Research, Secondary Research, Product Research, Trends And Forecast By 2026- Kite Pharma Inc., Thermo... - September 29th, 2020
- New research connects the hormones we're born with to lifetime risk for immunological diseases - MSUToday - September 20th, 2020
- School of Science grows by 10 - MIT News - September 10th, 2020
- COVID-19 Drug Discovery and Development Why Diverse Strategies Are Critical - Technology Networks - September 10th, 2020
- Researchers identify environmental components that affect gene expression in cardiovascular disease - The South End - June 21st, 2020
- Hesperos Human-on-a-Chip used to model Alzheimer's and MCI - SelectScience - June 2nd, 2020
- Are immune-compromised kids at greater risk from Covid-19? - Health24 - May 3rd, 2020
- Erika Hersch-Green Wins CAREER Award for Biodiversity Research - Michigan Tech News - May 2nd, 2020
- Science Becomes A Dividing Issue In Year Of Election And Pandemic - Michigan Radio - May 2nd, 2020
- In a CRISPR first, Editas therapy used to fix genes in the body - BioPharma Dive - March 11th, 2020
- Stopping Smoking Allows Healthy Lung Cells to Proliferate - Medscape - February 8th, 2020
- After a bone injury, shape-shifting cells rush to the rescue - University of Michigan News - January 29th, 2020
- Engineer the future of human health with a PhD in biomedical engineering - Study International News - January 29th, 2020
- The Unexpected Diversity of Pain - Scientific American - January 24th, 2020
- BREAKING: A woman gives birth to the Son of God (Part II) - INQUIRER.net - January 5th, 2020
- Collaborative Robots: Rai... - Robotics Online - December 19th, 2019
- VetStem Biopharma Shares the Success Story of Jesse Who was Treated with VetStem Cell Therapy - PR Web - December 8th, 2019
- Stem Cell Therapy Michigan | Regenerative Medicine 248-216 ... - February 27th, 2019
- Stem Cell Treatments Bloomfield Hills, MI | 248-216-1008 - January 9th, 2019
- Michigan Integrative Health Dr. Roy Picard, D.C. - December 27th, 2018
- Breast Cancer Stem Cells Stopping Them In Their Tracks ... - November 23rd, 2018
- Stem Cell Treatments MI | Michigan Center for Renerative ... - November 2nd, 2018
- Michigan Stem Cell Therapy - Foot HealthCare Associates - November 2nd, 2018
- Cancer Stem Cell Research | University of Michigan Rogel ... - November 2nd, 2018
- University of Michigan Stem Cell Research | Treatment and ... - November 2nd, 2018
- Detroit Michigan Stem Cell Therapy - americanregen.com - September 28th, 2018
- Combination of traditional chemotherapy, new drug kills ... - September 4th, 2018
- Stem Cells FAQ Michigan Stem Cell Institute - August 29th, 2018
- Anti-Aging, Regeneration and Stem Cell Supplements - August 7th, 2018
- Families raise money for research into rare diseases - KARE - September 8th, 2017
- Cells that stand in the way of HIV cure: Discovery expands understanding of marrow's role - Medical Xpress - August 5th, 2017
- Turmeric and black pepper fight cancer stem cells - November 26th, 2016
- Michigan company mines stem cells in search of Fountain of ... - November 18th, 2016
- stem cell research | Michigan Radio - October 6th, 2016
- Stem Cell Therapy Treatment at Allure Medical Spa in Michigan - October 6th, 2016
- University of Michigan Stem Cell Research | Experts List - September 20th, 2016
- Five years after Michigan vote on human embryonic stem ... - August 26th, 2016
- Scientists coax stem cells to form 3-D mini lungs ... - August 11th, 2016
- Cancer stem cells - University of Michigan Comprehensive ... - July 25th, 2016
- Michigan Catholic Conference: Home - October 19th, 2015
- Michigan Stem Cell Amendment, Proposal 2 (2008 ... - July 2nd, 2015
- University of Michigan Stem Cell Research | Embryo Donation - May 12th, 2015
- University of Michigan Stem Cell Research | Stem Cell ... - April 22nd, 2015
- How to grow a human lung - March 25th, 2015
- Novogen (NVGN) Promising Data in Brain Cancer; eFuture Information Technology (EFUT) and ... - March 5th, 2015
- Stem Cell Research - Right to Life of Michigan - February 24th, 2015
- Breast Cancer Stem Cell Research - University of Michigan ... - January 17th, 2015
- What makes pancreatic cancer so aggressive? New study sheds light - January 16th, 2015
- Leukemia Stem Cell Research | University of Michigan ... - January 4th, 2015
- Seeing Is Believing - December 12th, 2014
- Swiston receives Commitment to Education Award - November 29th, 2014
- Bone marrow registration drive to be held at Saint Mary's College - November 18th, 2014
- Researchers devise a means for growing near 2-D chemical gardens (w/ Video) - November 11th, 2014
- Stem cells help doctors restore womans smile, regenerating bone to hold dental implants - November 5th, 2014
- Reason to Bree-Lieve: Greenville girl continues to beat the odds - November 5th, 2014